Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient
Playback speed
10 seconds
DLBCL: Immune Modulation Therapy Including CAR-T, Bispecific Antibodies, and New Antibodies
214 views
February 15, 2023
Comments 0
Login to view comments.
Click here to Login
Videos